Clinical Data Major trial of Roche Alzheimer’s drug kicks off in Europe PharmaphorumThe PrevenTRON trial of Roche's Brainshuttle drug trontinemab in preclinical Alzheimer's disease has gotten underway in the UK.NeuroscienceRead full story pharminent September 7, 2026 (Last updated: September 7, 2026) Pharmaphorum The PrevenTRON trial of Roche’s Brainshuttle drug trontinemab in preclinical Alzheimer’s disease has gotten underway in the UK. Neuroscience Read full story Post navigation Previous: Ionis Wins First-Ever FDA Approval for Alexander Disease with ZanvastroNext: UK’s Claret Capital raises 575m for European biotechs Related Stories Clinical Data AbbVie’s T cell engager delivers survival benefit in Phase 3 multiple myeloma study pharminent September 4, 2026 Clinical Data Summit, Akeso’s ivonescimab bests Merck’s Keytruda in China trial–again pharminent September 3, 2026 Clinical Data Autoimmune CAR-T faces tough questions after Novartis, Bristol Myers study halts pharminent September 2, 2026